Related Experiment Video

Updated: Aug 19, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

A gene for a myosin peptide is disrupted by the inv(16)(p13q22) in acute nonlymphocytic leukemia M4Eo

B A van der Reijden1, J G Dauwerse, J W Wessels

  • 1Department of Human Genetics, Leiden University, The Netherlands.

Blood
|November 15, 1993
PubMed

Insights

Researchers identified a myosin gene disrupted by chromosome 16 inversions in acute nonlymphocytic leukemia (ANLL) M4Eo subtype. This finding offers new insights into leukemia genetics and potential therapeutic targets.

Area of Science:

  • Hematology
  • Cancer Genetics
  • Molecular Biology

Background:

  • Chromosome 16 aberrations are frequently observed in acute nonlymphocytic leukemia (ANLL).
  • The inversion of chromosome 16, specifically inv(16)(p13q22), is the most common aberration in ANLL subtype M4Eo.
  • Previous studies indicated clustered breakpoints within a 14-kb genomic fragment on the short arm of chromosome 16 in ANLL M4Eo patients.

Purpose of the Study:

  • To identify the specific gene affected by the chromosome 16 inversion in ANLL M4Eo.
  • To investigate the role of this disrupted gene in the pathogenesis of ANLL.
  • To report the first instance of a myosin gene disruption in leukemia.

Main Methods:

  • Analysis of genomic DNA from five ANLL M4Eo patients with inv(16)(p13q22).
  • Characterization of the 14-kb genomic EcoRI fragment containing the breakpoint.
  • Gene identification and sequencing within the critical genomic region.

Main Results:

  • A novel gene encoding a myosin peptide was identified within the 14-kb fragment.
  • This myosin gene is disrupted by the inv(16)(p13q22) in all five studied ANLL M4Eo patients.
  • This represents the first documented case of a myosin gene alteration in leukemia.

Conclusions:

  • The inversion of chromosome 16 in ANLL M4Eo disrupts a myosin gene.
  • This myosin gene disruption is a key event in the molecular pathogenesis of this leukemia subtype.
  • The findings open new avenues for understanding ANLL and developing targeted therapies.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice10:02

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice

Published on: January 6, 2023

Related Concept Videos

In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...